Week-by-week titration for sublingual semaglutide drops The following schedule represents a common compounded sublingual semaglutide titration
GLOW focuses on regeneration, collagen production, and visible tissue repair KLOW supports regeneration while actively controlling inflammation and immune stress If inflammation is minimal and the goal is skin rejuvenation or aesthetic recovery, GLOW is typically sufficient
The recommended dosing schedule is as follows: Weeks 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1 mg once weekly Week 13 and beyond: 2.4 mg once weekly Considerations for Plastic Surgery Patients As a plastic surgeon, I often discuss the potential benefits of Mounjaro and Semaglutide with my patients
Michael K.
Current medicines: Insulin, sulfonylureas, steroids, or GI-slowing drugs
Although there has been no direct head-to-head study comparing between the two preparations of semaglutide, the SUSTAIN-1 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide against placebo in 387 T2D patients using a similar study design and patient population to PIONEER-1